Perfil
Dr. Joern-Peter Halle is a Venture Partner at Biogeneration Management BV and a Chief Strategy Officer at Merck KGaA.
Dr. Halle also served on the board at iOnctura SA.
He received his doctorate degree from Universität Konstanz.
Cargos activos de Joern-Peter Halle
| Empresas | Cargo | Inicio |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01/01/2022 |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Inversor de Capital Privado | 01/04/2024 |
Antiguos cargos conocidos de Joern-Peter Halle.
| Empresas | Cargo | Fin |
|---|---|---|
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Director/Miembro de la Junta | - |
Formación de Joern-Peter Halle.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität Konstanz
Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Finance |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
- Bolsa de valores
- Insiders
- Joern-Peter Halle
















